Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).
Saved in:
| Title: | Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). |
|---|---|
| Authors: | Correale P; Section of Medical Oncology, Department 'Giorgio Segre' of Pharmacology, Rheumatology Unit, Siena University School of Medicine, Siena, Italy., Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C, Montagnani F, Rotundo MS, Ginanneschi C, Martellucci I, Francini E, Cusi MG, Tassone P, Francini G |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2008 Jul 01; Vol. 14 (13), pp. 4192-9. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 18593999 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Correale+P%22">Correale P</searchLink>; Section of Medical Oncology, Department 'Giorgio Segre' of Pharmacology, Rheumatology Unit, Siena University School of Medicine, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Tagliaferri+P%22">Tagliaferri P</searchLink><br /><searchLink fieldCode="AU" term="%22Fioravanti+A%22">Fioravanti A</searchLink><br /><searchLink fieldCode="AU" term="%22Del+Vecchio+MT%22">Del Vecchio MT</searchLink><br /><searchLink fieldCode="AU" term="%22Remondo+C%22">Remondo C</searchLink><br /><searchLink fieldCode="AU" term="%22Montagnani+F%22">Montagnani F</searchLink><br /><searchLink fieldCode="AU" term="%22Rotundo+MS%22">Rotundo MS</searchLink><br /><searchLink fieldCode="AU" term="%22Ginanneschi+C%22">Ginanneschi C</searchLink><br /><searchLink fieldCode="AU" term="%22Martellucci+I%22">Martellucci I</searchLink><br /><searchLink fieldCode="AU" term="%22Francini+E%22">Francini E</searchLink><br /><searchLink fieldCode="AU" term="%22Cusi+MG%22">Cusi MG</searchLink><br /><searchLink fieldCode="AU" term="%22Tassone+P%22">Tassone P</searchLink><br /><searchLink fieldCode="AU" term="%22Francini+G%22">Francini G</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2008 Jul 01; Vol. 14 (13), pp. 4192-9. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1078-0432 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18593999 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-07-5278 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4192 Titles: – TitleFull: Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Correale P – PersonEntity: Name: NameFull: Tagliaferri P – PersonEntity: Name: NameFull: Fioravanti A – PersonEntity: Name: NameFull: Del Vecchio MT – PersonEntity: Name: NameFull: Remondo C – PersonEntity: Name: NameFull: Montagnani F – PersonEntity: Name: NameFull: Rotundo MS – PersonEntity: Name: NameFull: Ginanneschi C – PersonEntity: Name: NameFull: Martellucci I – PersonEntity: Name: NameFull: Francini E – PersonEntity: Name: NameFull: Cusi MG – PersonEntity: Name: NameFull: Tassone P – PersonEntity: Name: NameFull: Francini G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2008 Jul 01 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 1078-0432 Numbering: – Type: volume Value: 14 – Type: issue Value: 13 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |
